Skip to main content
logo
BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.205
-0.015 (-1.23%)
May 11, 2026, 4:00 PM EDT - Market closed

BioXcel Therapeutics Revenue

In the year 2025, BioXcel Therapeutics had annual revenue of $642.00K, down -71.67%. BioXcel Therapeutics had revenue of $256.00K in the quarter ending December 31, 2025, a decrease of -30.05%.

Revenue (ttm)
$642.00K
Revenue Growth
-71.67%
P/S Ratio
51.45
Revenue / Employee
$22,138
Employees
29
Market Cap
32.62M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025642.00K-1.62M-71.67%
Dec 31, 20242.27M886.00K64.20%
Dec 31, 20231.38M1.01M268.00%
Dec 31, 2022375.00K--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
InterCure84.76M
Rockwell Medical67.68M
Aytu BioPharma62.64M
Cumberland Pharmaceuticals41.94M
BGM Group25.10M
Zhengye Biotechnology Holding16.64M
China Pharma Holdings4.14M
TherapeuticsMD3.02M
Revenue Rankings

BTAI News

More News